Gene therapy approval advances for Duchenne MD | Psychotherapy for depression in pregnancy | Child neglect links to poor health later | Protection against eye injury
From Health Report
Published 5/15/2023
The U.S. Food and Drug Administration (FDA) have voted that when they meet formally at the end of May, approval goes forward for a treatment for Duchenne muscular dystrophy—a disabling genetic disease.Post partum depression is a significant issue for both women and their babies, and it doesn't come…
